Back to Search
Start Over
519P Final results and subgroup analysis of ORIENTAL: A phase IIIB study of durvalumab plus platinum-etoposide in first-line treatment of Chinese patients with extensive-stage small-cell lung cancer (ES-SCLC).
- Source :
-
Annals of Oncology . 2023 Supplement 4, Vol. 34, pS1673-S1673. 1p. - Publication Year :
- 2023
- Subjects :
- *CHINESE people
*LUNG cancer
*SUBGROUP analysis (Experimental design)
*THERAPEUTICS
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 34
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 173758477
- Full Text :
- https://doi.org/10.1016/j.annonc.2023.10.598